rs186687142

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001039213.4(CEACAM16):​c.95G>T​(p.Ser32Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00161 in 1,613,786 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar. Synonymous variant affecting the same amino acid position (i.e. S32S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0018 ( 2 hom., cov: 32)
Exomes 𝑓: 0.0016 ( 6 hom. )

Consequence

CEACAM16
NM_001039213.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0190

Publications

2 publications found
Variant links:
Genes affected
CEACAM16 (HGNC:31948): (CEA cell adhesion molecule 16, tectorial membrane component) The protein encoded by this gene is a secreted glycoprotein that in mouse interacts with tectorial membrane proteins in the inner ear. The encoded adhesion protein is found in cochlear outer hair cells and appears to be important for proper hearing over an extended frequency range. Defects in this gene likely are a cause of non-syndromic autosomal dominant hearing loss. [provided by RefSeq, May 2012]
CEACAM16-AS1 (HGNC:55317): (CEACAM16, CEACAM19 and PVR antisense RNA 1)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0069971085).
BP6
Variant 19-44703406-G-T is Benign according to our data. Variant chr19-44703406-G-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 226511.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00182 (277/152320) while in subpopulation AMR AF = 0.00954 (146/15300). AF 95% confidence interval is 0.00828. There are 2 homozygotes in GnomAd4. There are 132 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEACAM16NM_001039213.4 linkc.95G>T p.Ser32Ile missense_variant Exon 3 of 7 ENST00000587331.7 NP_001034302.2 Q2WEN9
CEACAM16XM_017026795.2 linkc.95G>T p.Ser32Ile missense_variant Exon 2 of 5 XP_016882284.1
CEACAM16-AS1NR_186815.1 linkn.348-4229C>A intron_variant Intron 1 of 1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEACAM16ENST00000587331.7 linkc.95G>T p.Ser32Ile missense_variant Exon 3 of 7 1 NM_001039213.4 ENSP00000466561.1 Q2WEN9

Frequencies

GnomAD3 genomes
AF:
0.00183
AC:
279
AN:
152202
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000362
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00969
Gnomad ASJ
AF:
0.000577
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000942
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00144
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00196
AC:
488
AN:
248360
AF XY:
0.00168
show subpopulations
Gnomad AFR exome
AF:
0.000195
Gnomad AMR exome
AF:
0.00785
Gnomad ASJ exome
AF:
0.000299
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000836
Gnomad NFE exome
AF:
0.00165
Gnomad OTH exome
AF:
0.00133
GnomAD4 exome
AF:
0.00159
AC:
2327
AN:
1461466
Hom.:
6
Cov.:
32
AF XY:
0.00153
AC XY:
1116
AN XY:
727034
show subpopulations
African (AFR)
AF:
0.000239
AC:
8
AN:
33480
American (AMR)
AF:
0.00899
AC:
402
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.000191
AC:
5
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.000921
AC:
49
AN:
53194
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5752
European-Non Finnish (NFE)
AF:
0.00158
AC:
1757
AN:
1111864
Other (OTH)
AF:
0.00174
AC:
105
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.454
Heterozygous variant carriers
0
131
262
393
524
655
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00182
AC:
277
AN:
152320
Hom.:
2
Cov.:
32
AF XY:
0.00177
AC XY:
132
AN XY:
74490
show subpopulations
African (AFR)
AF:
0.000361
AC:
15
AN:
41584
American (AMR)
AF:
0.00954
AC:
146
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.000577
AC:
2
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.000942
AC:
10
AN:
10618
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00144
AC:
98
AN:
68012
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
14
27
41
54
68
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00154
Hom.:
0
Bravo
AF:
0.00265
TwinsUK
AF:
0.00108
AC:
4
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00132
AC:
11
ExAC
AF:
0.00190
AC:
230
Asia WGS
AF:
0.000577
AC:
2
AN:
3478
EpiCase
AF:
0.00120
EpiControl
AF:
0.00172

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
May 30, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Aug 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CEACAM16: BP4, BS2 -

not specified Benign:1
May 14, 2015
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Ser32Ile in exon 3 of CEACAM16: This variant is not expected to have clinical significance because it has been identified in 0.9% (109/11536) of Latino chromo somes including 3 homozygotes by the Exome Aggregation Consortium (ExAC, http:// exac.broadinstitute.org; dbSNP rs186687142). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.54
T
BayesDel_noAF
Benign
-0.55
CADD
Benign
9.1
DANN
Benign
0.96
DEOGEN2
Benign
0.051
T;T
Eigen
Benign
-0.92
Eigen_PC
Benign
-0.93
FATHMM_MKL
Benign
0.011
N
LIST_S2
Benign
0.57
.;T
MetaRNN
Benign
0.0070
T;T
MetaSVM
Benign
-0.94
T
MutationAssessor
Benign
1.1
L;L
PhyloP100
0.019
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.9
.;N
REVEL
Benign
0.042
Sift
Uncertain
0.0060
.;D
Sift4G
Benign
0.069
T;T
Vest4
0.20
MVP
0.47
MPC
0.17
ClinPred
0.010
T
GERP RS
1.9
Varity_R
0.085
gMVP
0.50
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs186687142; hg19: chr19-45206676; API